Prostaglandin E1 as a Screening Vasodilator in Primary Pulmonary Hypertension
- 1 October 1987
- Vol. 92 (4) , 686-691
- https://doi.org/10.1378/chest.92.4.686
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertensionThe American Journal of Cardiology, 1984
- Captopril Versus Hydralazine in Primary Pulmonary HypertensionThe Journal of Clinical Pharmacology, 1983
- Hydralazine in Pulmonary HypertensionNew England Journal of Medicine, 1982
- Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation, 1982
- Deleterious Effects of Hydralazine in Patients with Pulmonary HypertensionNew England Journal of Medicine, 1982
- Unexplained pulmonary hypertension.Circulation, 1982
- The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause.Circulation, 1982
- Primary pulmonary hypertension: effects of nifedipine.Heart, 1981
- Inhibition of Hypoxic Pulmonary Vasoconstriction by NifedipineNew England Journal of Medicine, 1981
- PROSTACYCLIN AND PROSTAGLANDIN E1 FOR SEVERE IDIOPATHIC PULMONARY ARTERY HYPERTENSIONThe Lancet, 1980